Biomerics yesterday announced the opening of a 2,000 sq. ft. Balloons & Balloon Catheters Centre of Excellence in Galway and the creation of approximately 40 jobs over the next five years.
This is Biomerics' first facility in Europe and the second facility outside the United States after Costa Rica. It will become home to a growing team dedicated to the development and manufacturing of balloons and balloon catheters and act as an extension to the operations in Athens, TX.
The new office will be located at 2 Liosban Business Park in Galway. Biomerics say they chose Galway due to the region’s significant cluster of medical device companies, a skilled labor pool, an international reputation, and access to suppliers and vendors. The office will be equipped with multiple balloon-forming machines, state-of-the-art test equipment, and a cleanroom that is ISO 13485:2016 certified.
Founded in 1994, Biomerics is the vertically integrated medical device contract manufacturer serving the interventional device market. Trusted as a partner with extensive engineering expertise and solutions, Biomerics supplies 20 of the top 30 medical device OEMs.
Biomerics provides engineering design and development services, technical transfer manufacturing services, and contract manufacturing services – including sterilization and packaging - for medical devices components, subassemblies, and finished medical devices through eight locations in the United States, Ireland, and Costa Rica – to meet immediate and long-term strategic needs.
Speaking yesterday, Galway-based Minister of State in the Department of Transport Hildegarde Naughton said, "I am delighted to welcome Biomerics to Ireland and indeed to Galway where it has chosen to establish its Balloons & Balloon Catheters Centre of Excellence. This move brings with it the creation of 40 jobs providing new opportunities for people to work and live in Galway, which has a proven track record when it comes to providing a rich pool of talent with a highly skilled and educated workforce. Today’s announcement is a great achievement for the West of Ireland and signals a bright future for businesses across the country."
"Having this new location is another step in our strategic growth plan. We continue to see a strong need around balloon component development," says Todd McFarland, President of Biomerics FMI. "Our focus will be on next-generation technologies, including micro- and sensing balloons. Additionally, the facility will provide more capacity to support our strategic customers in the interventional markets we serve."